{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:37:48Z","timestamp":1792024668791,"version":"4.4.0"},"reference-count":33,"publisher":"European Respiratory Society (ERS)","issue":"2","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,4,13]]},"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypersensitivity pneumonitis is an immune-mediated disease triggered by exposure to organic particles in susceptible individuals. It has been reported that a subgroup of patients with hypersensitivity pneumonitis develops autoantibodies with or without clinical manifestations of autoimmune disease. However, the mechanisms involved in this process and the effect of the autoantibodies on clinical course in hypersensitivity pneumonitis is unknown. We evaluated the association between human leukocyte antigen (HLA) class II alleles and hypersensitivity pneumonitis patients with and without autoantibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      170 hypersensitivity pneumonitis patients were included. We analysed the presence of antinuclear antibodies, rheumatoid factor, anti-SSA\/Ro, anti-SSB\/La and anti-CCP at the time of diagnosis. In addition, in a subset of patients we evaluated anti-Scl-70, anti-neutrophil cytoplasmic antibody, and anti-DNA. HLA typing was performed using PCR sequence-specific primers in a high-resolution modality, including\n                      <jats:italic>HLA-DRB1<\/jats:italic>\n                      and\n                      <jats:italic>HLA-DQB1<\/jats:italic>\n                      loci. Statistical analysis was performed employing Epi-Info v7 and SPSS v20.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      60 hypersensitivity pneumonitis patients showed sera autoantibodies (HPAbs\n                      <jats:sup>+<\/jats:sup>\n                      ), and 110 hypersensitivity pneumonitis patients did not (HPAbs\n                      <jats:sup>\u2212<\/jats:sup>\n                      ). The frequency of the allele\n                      <jats:italic>HLA-DRB1*03:01<\/jats:italic>\n                      was remarkably increased in the HPAbs\n                      <jats:sup>+<\/jats:sup>\n                      group (10.8%\n                      <jats:italic>versus<\/jats:italic>\n                      0.45%; OR 30.14, 95% CI 3.83\u2013237.1; p=1.65\u00d710\n                      <jats:sup>-4<\/jats:sup>\n                      after Bonferroni's correction). Likewise, we found that the haplotype\n                      <jats:italic>DRB1*03:01-DQB1*02:01<\/jats:italic>\n                      , which is part of the 8.1 ancestral haplotype, a major genetic determinant of autoimmune diseases, confers significant risk to develop autoantibodies (OR 19.23, 95% CI 2.37\u2013155.9; p=0.0088 after Bonferroni's correction). In addition, the\n                      <jats:italic>HLA-DRB1*03:01<\/jats:italic>\n                      allele was associated with higher mortality in patients with hypersensitivity pneumonitis (adjusted OR 5.9, 95% CI 1.05\u201333.05; p=0.043).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A subset of hypersensitivity pneumonitis patients presents circulating autoantibodies and higher mortality that are associated with some alleles of 8.1 ancestral haplotype.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/13993003.01380-2019","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T20:35:47Z","timestamp":1588624547000},"page":"1901380","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis"],"prefix":"10.1183","volume":"56","author":[{"given":"Ivette","family":"Buend\u00eda-Rold\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Santiago-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"P\u00e9rez-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra","family":"Mej\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rojas-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Ambrocio-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geovanni","family":"Ben\u00edtez-Valdez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-4783","authenticated-orcid":false,"given":"Mois\u00e9s","family":"Selman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-8124","authenticated-orcid":false,"given":"Ramc\u00e9s","family":"Falf\u00e1n-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"2024102101361507000_56.2.1901380.1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.iac.2012.08.008","article-title":"Hypersensitivity pneumonitis","volume":"32","author":"Ohshimo","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"key":"2024102101361507000_56.2.1901380.2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201203-0513CI"},{"key":"2024102101361507000_56.2.1901380.3","first-page":"237","article-title":"Hypersensitivity pneumonitis: a comprehensive review","volume":"25","author":"Spagnolo","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2024102101361507000_56.2.1901380.4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.201903-0541PP","article-title":"Hypersensitivity pneumonitis: current concepts of pathogenesis and potential targets for treatment","volume":"200","author":"Vasakova","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101361507000_56.2.1901380.5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1325163"},{"key":"2024102101361507000_56.2.1901380.6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201611-2201PP","article-title":"Hypersensitivity pneumonitis: perspectives in diagnosis and management","volume":"196","author":"Vasakova","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101361507000_56.2.1901380.7","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1164\/ajrccm.163.7.2004023","article-title":"Major histocompatibility complex and tumor necrosis factor-\u03b1 polymorphisms in pigeon breeder's disease","volume":"163","author":"Camarena","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2024102101361507000_56.2.1901380.8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.rmed.2013.11.004","article-title":"Genetic susceptibility to multicase hypersensitivity pneumonitis is associated with the TNF-238 GG genotype of the promoter region and HLA-DRB1*04 bearing HLA haplotypes","volume":"108","author":"Falf\u00e1n-Valencia","year":"2014","journal-title":"Respir Med"},{"key":"2024102101361507000_56.2.1901380.9","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/144.4.765"},{"key":"2024102101361507000_56.2.1901380.10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/tan.13305","article-title":"Autoimmune diseases and 8.1 ancestral haplotype: an update","volume":"92","author":"Gambino","year":"2018","journal-title":"HLA"},{"key":"2024102101361507000_56.2.1901380.11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.rmed.2016.03.012","article-title":"Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features","volume":"114","author":"Adegunsoye","year":"2016","journal-title":"Respir Med"},{"key":"2024102101361507000_56.2.1901380.12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.3109\/15412555.2016.1161017","article-title":"Genetic variants in IL6R and ADAM19 are associated with COPD severity in a Mexican mestizo population","volume":"13","author":"P\u00e9rez-Rubio","year":"2016","journal-title":"COPD"},{"key":"2024102101361507000_56.2.1901380.13","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201407-1334OC"},{"key":"2024102101361507000_56.2.1901380.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-093OC"},{"key":"2024102101361507000_56.2.1901380.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210571"},{"key":"2024102101361507000_56.2.1901380.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"2024102101361507000_56.2.1901380.17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150694"},{"key":"2024102101361507000_56.2.1901380.18","unstructured":"Dean AG , Arner TG , Sunki GG , et al. Epi Info, a Database and Statistics Program for Public Health Professionals. 2004. www.cdc.gov\/epiinfo\/index.html"},{"key":"2024102101361507000_56.2.1901380.19","first-page":"47","article-title":"Arlequin (version 3.0): an integrated software package for population genetics data analysis","volume":"1","author":"Excoffier","year":"2007","journal-title":"Evol Bioinform Online"},{"key":"2024102101361507000_56.2.1901380.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2010.01.014"},{"key":"2024102101361507000_56.2.1901380.21","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00150-2015"},{"key":"2024102101361507000_56.2.1901380.22","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10067-018-4111-5","article-title":"Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study","volume":"37","author":"Dai","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2024102101361507000_56.2.1901380.23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CPM.0000000000000227","article-title":"Interstitial pneumonia with autoimmune features: overview of proposed criteria and recent cohort characterization","volume":"24","author":"Lee","year":"2017","journal-title":"Clin Pulm Med"},{"key":"2024102101361507000_56.2.1901380.24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5144\/0256-4947.2013.229","article-title":"Association of HLA-DRB1*15 and HLADQB1*06 with SLE in Saudis","volume":"33","author":"Al-Motwee","year":"2013","journal-title":"Ann Saudi Med"},{"key":"2024102101361507000_56.2.1901380.25","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2014.6"},{"key":"2024102101361507000_56.2.1901380.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep248"},{"key":"2024102101361507000_56.2.1901380.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200182"},{"key":"2024102101361507000_56.2.1901380.28","doi-asserted-by":"publisher","DOI":"10.1186\/ar1862"},{"key":"2024102101361507000_56.2.1901380.29","doi-asserted-by":"publisher","DOI":"10.1111\/1348-0421.12020"},{"key":"2024102101361507000_56.2.1901380.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1727"},{"key":"2024102101361507000_56.2.1901380.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2004.11.008"},{"key":"2024102101361507000_56.2.1901380.32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","article-title":"The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study","volume":"5","author":"Ley","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2024102101361507000_56.2.1901380.33","doi-asserted-by":"publisher","DOI":"10.1016\/S0047-6374(00)00255-4"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01380-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T02:32:47Z","timestamp":1740364367000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01380-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.1183\/13993003.01380-2019"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01380-2019","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737901555.793574517","asserted-by":"object"}]},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}